NEW YORK, Sept. 3, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) (“NeoStem” or the “Company”), a leader in the emerging cellular therapy market, announced today that the Company and its subsidiary, Progenitor Cell Therapy (“PCT”), will present at multiple upcoming conferences in September.
Help employers find you! Check out all the jobs and post your resume.
